Waters Corporation Engages Paul Hastings for $17.5 Billion Financing Deal

Deal News | Jul 15, 2025 | Paul Hastings

Waters Corporation Engages Paul Hastings for $17.5 Billion Financing Deal

In a significant transaction, Paul Hastings LLP is advising on committed financing for a $17.5 billion Reverse Morris Trust combination involving Waters Corporation and Becton Dickinson's Biosciences & Diagnostic Solutions business. The legal expertise is led by finance partner Morgan Bale, with a team that includes experts in capital markets, M&A, and tax law. Paul Hastings is recognized globally for its superior execution and intellectual capital, making it a preferred choice for leading financial institutions and corporations.

Sectors

  • Legal Services
  • Healthcare and Diagnostics
  • Finance

Geography

  • United States – The companies involved, Waters Corporation and Becton Dickinson, are U.S.-based, indicating the geographical relevance.

Industry

  • Legal Services – Paul Hastings LLP's involvement as legal advisor highlights the role of legal services in facilitating major financial transactions.
  • Healthcare and Diagnostics – The transaction involves Becton Dickinson's Biosciences & Diagnostic Solutions, indicating relevance to the healthcare and diagnostics industry.
  • Finance – The deal involves committed financing, showcasing the financial industry's role in structuring and supporting large mergers.

Financials

  • $17.5 billion – The total value of the Reverse Morris Trust combination.

Participants

NameRoleTypeDescription
Paul Hastings LLPLegal AdvisorCompanyAn elite law firm advising on the committed financing for the transaction.
Waters CorporationParticipant CompanyCompanyThe company involved in the Reverse Morris Trust combination.
Becton Dickinson (BD)
Participant CompanyCompanyThe company whose Biosciences & Diagnostic Solutions business is part of the transaction.